Aequus Pharmaceuticals Inc.
AQS.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -118.50K | -449.50K | -155.60K | -450.70K | -499.20K |
| Total Depreciation and Amortization | 0.00 | 23.10K | 23.60K | 24.30K | 24.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.10K | 339.60K | -2.40K | 16.50K | 23.50K |
| Change in Net Operating Assets | 74.50K | 108.90K | 77.60K | 154.30K | -64.50K |
| Cash from Operations | -33.90K | 22.10K | -56.80K | -255.70K | -516.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 32.00K | -- | -- |
| Cash from Investing | -- | -- | 32.00K | -- | -- |
| Total Debt Issued | -- | -- | 101.60K | 371.90K | 550.00K |
| Total Debt Repaid | 42.80K | -42.80K | -42.20K | -41.90K | -41.90K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.90K | -29.80K | 42.50K | 242.00K | 371.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 110.70K |
| Net Change in Cash | -3.00K | -7.70K | 17.70K | -13.70K | -34.00K |